VALERIO THERAPEUTICS EUR0.25 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0NWK for the last semiannual is 89.00 k EUR, and it's 95.06% lower compared to the previous semiannual. The net income of H1 24 is -10.96 M EUR.